{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:57:28Z","timestamp":1793228248679,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273549"],"award-info":[{"award-number":["82273549"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["SBK2022023090"],"award-info":[{"award-number":["SBK2022023090"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202228"],"award-info":[{"award-number":["JSDW202228"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02332-2","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:54:35Z","timestamp":1751518475000},"page":"4379-4397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Comparative Analysis Dissecting the Immune Landscape of Vitiligo and Melanoma from a single-cell Perspective: Two Sides of the Same Coin?"],"prefix":"10.1007","volume":"48","author":[{"given":"Yongkai","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"2332_CR1","doi-asserted-by":"crossref","unstructured":"Rodrigues, M., K. Ezzedine, I. Hamzavi, and A. G. Pandya. 2017. J. E. Harris. New discoveries in the pathogenesis and classification of vitiligo. Journal of the American Academy of Dermatology,;77.","DOI":"10.1016\/j.jaad.2016.10.048"},{"key":"2332_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12949","volume":"34","author":"J Seneschal","year":"2021","unstructured":"Seneschal, J., K. Boniface, and A. D\u2019Arino. 2021. Picardo. An update on vitiligo pathogenesis. Pigment Cell Melanoma Res 34:236\u2013243.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2332_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaci.2017.07.011","volume":"140","author":"ML Frisoli","year":"2017","unstructured":"Frisoli, M. L., and J. E. Harris. 2017. Vitiligo: Mechanistic insights lead to novel treatments. The Journal of Allergy and Clinical Immunology 140:654\u2013662.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"2332_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11912-008-0067-y","volume":"10","author":"J Villanueva","year":"2008","unstructured":"Villanueva, J., and M. Herlyn. 2008. Melanoma and the tumor microenvironment. Current Oncology Reports 10:439\u2013446.","journal-title":"Current Oncology Reports"},{"key":"2332_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/pcmr.12239","volume":"27","author":"P Falletta","year":"2014","unstructured":"Falletta, P., P. Bagnato, M. Bono, M. Monticone, M. V. Schiaffino, and D. C. Bennett et al. 2014. Melanosome-autonomous regulation of size and number: The OA1 receptor sustains PMEL expression. Pigment Cell Melanoma Res 27:565\u2013579.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2332_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/pcmr.12499","volume":"29","author":"Y Bu","year":"2016","unstructured":"Bu, Y., and J. A. Diehl. 2016. Stressing out melanoma with an anti-GRP78 compound. Pigment Cell Melanoma Res 29:490\u2013491.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2332_CR7","doi-asserted-by":"crossref","unstructured":"Sykes, E. K., and S. Mactier. 2016. R. I. Christopherson. Melanoma and the unfolded protein response. Cancers (Basel),;8.","DOI":"10.3390\/cancers8030030"},{"key":"2332_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2014.57.4756","volume":"33","author":"H-E Teulings","year":"2015","unstructured":"Teulings, H.-E., J. Limpens, S. N. Jansen, A. H. Zwinderman, J. B. Reitsma, and P. I. Spuls et al. 2015. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: A systematic review and meta-analysis. Journal of Clinical Oncology 33:773\u2013781.","journal-title":"Journal of Clinical Oncology"},{"key":"2332_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41571-020-00449-x","volume":"18","author":"SH Gohil","year":"2021","unstructured":"Gohil, S. H., J. B. Iorgulescu, D. A. Braun, and D. B. Keskin. 2021. Livak. Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy. Nature Reviews. Clinical Oncology 18:244\u2013256.","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"2332_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","volume":"22","author":"C Ma","year":"2023","unstructured":"Ma, C., C. Yang, A. Peng, T. Sun, X. Ji, and J. Mi et al. 2023. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Molecular Cancer 22:170.","journal-title":"Molecular Cancer"},{"key":"2332_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","volume":"601","author":"Z Xu","year":"2022","unstructured":"Xu, Z., D. Chen, Y. Hu, K. Jiang, H. Huang, and Y. Du et al. 2022. Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature 601:118\u2013124.","journal-title":"Nature"},{"key":"2332_CR12","doi-asserted-by":"crossref","unstructured":"Stuart, T., A. Butler, P. Hoffman, C. Hafemeister, E. Papalexi, and W. M. Mauck et al. 2019. Comprehensive Integration of Single-Cell Data. Cell,;177.","DOI":"10.1101\/460147"},{"key":"2332_CR13","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L., S. Qin, W. Si, A. Wang, B. Xing, and R. Gao et al. 2021. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374:abe6474.","journal-title":"Science"},{"key":"2332_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41587-020-0605-1","volume":"39","author":"MA Skinnider","year":"2021","unstructured":"Skinnider, M. A., J. W. Squair, C. Kathe, M. A. Anderson, M. Gautier, and K. J. E. Matson et al. 2021. Cell type prioritization in single-cell data. Nature Biotechnology 39:30\u201334.","journal-title":"Nature Biotechnology"},{"key":"2332_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., R. Castelo, and J. Guinney. 2013. GSVA: Gene set variation analysis for microarray and RNA-seq data. Bmc Bioinformatics 14:7.","journal-title":"Bmc Bioinformatics"},{"key":"2332_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S., C.F. Guerrero-Juarez, L. Zhang, I. Chang, R. Ramos, C.H. Kuan, et al. 2021. Inference and analysis of cell-cell communication using Cell Chat. Nature Communication 12: 1088.","journal-title":"Nature Communication"},{"key":"2332_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S., C. B. Gonz\u00e1lez-Blas, T. Moerman, V. A. Huynh-Thu, H. Imrichova, and G. Hulselmans et al. 2017. SCENIC: single-cell regulatory network inference and clustering. Nature Methods 14:1083\u20131086.","journal-title":"Nature Methods"},{"key":"2332_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I., B. Izar, S. M. Prakadan, M. H. Wadsworth, D. Treacy, and J. J. Trombetta et al. 2016. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352:189\u2013196.","journal-title":"Science"},{"key":"2332_CR19","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1158\/2159-8290.CD-22-0943","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang, L. 2022. Developmental Deconvolution suggests new tumor biology and a tool for predicting Cancer origin. Cancer Discovery 12:2498\u20132500.","journal-title":"Cancer Discovery"},{"key":"2332_CR20","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.redox.2023.102831","volume":"65","author":"F-J Lei","year":"2023","unstructured":"Lei, F.-J., J.-Y. Chiang, H.-J. Chang, D.-C. Chen, H.-L. Wang, and H.-A. Yang et al. 2023. Cellular and Exosomal GPx1 are essential for controlling hydrogen peroxide balance and alleviating oxidative stress in hypoxic glioblastoma. Redox Biology 65:102831.","journal-title":"Redox Biology"},{"key":"2332_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00011-016-0995-1","volume":"66","author":"H Su","year":"2017","unstructured":"Su, H., N. Na, X. Zhang, and Y. Zhao. 2017. The biological function and significance of CD74 in immune diseases. Inflammation Research 66:209\u2013216.","journal-title":"Inflammation Research"},{"key":"2332_CR22","doi-asserted-by":"publisher","first-page":"188502","DOI":"10.1016\/j.bbcan.2021.188502","volume":"1875","author":"B Goyal","year":"2021","unstructured":"Goyal, B., S. R. M. Yadav, N. Awasthee, S. Gupta, and A. B. Kunnumakkara. 2021. Gupta. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. Biochimica Et Biophysica Acta - Reviews on Cancer 1875:188502.","journal-title":"Biochimica Et Biophysica Acta - Reviews on Cancer"},{"key":"2332_CR23","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/jca.60118","volume":"12","author":"L Song","year":"2021","unstructured":"Song, L., Z. Chen, M. Zhang, M. Zhang, X. Lu, and C. Li et al. 2021. DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma. Journal of Cancer 12:6422\u20136428.","journal-title":"Journal of Cancer"},{"key":"2332_CR24","doi-asserted-by":"crossref","unstructured":"Shiu, J., L. Zhang, G. Lentsch, J. L. Flesher, S. Jin, and C. Polleys et al. 2022. Multimodal analyses of vitiligo skin identify tissue characteristics of stable disease. JCI Insight 7:e154585.","DOI":"10.1172\/jci.insight.154585"},{"key":"2332_CR25","doi-asserted-by":"crossref","unstructured":"Failla, C. M., M. L. Carbone, C. Fortes, G. Pagnanelli.,\u00a0S. D'Atri. 2019. S. D\u2019Atri. Melanoma and Vitiligo: In Good Company. International Journal of Molecular Sciences 20:5731.","DOI":"10.3390\/ijms20225731"},{"key":"2332_CR26","doi-asserted-by":"publisher","first-page":"866703","DOI":"10.3389\/fimmu.2022.866703","volume":"13","author":"K Fukuda","year":"2022","unstructured":"Fukuda, K. 2022. Networks of CD8\u2009+\u2009T cell response activation in melanoma and vitiligo. Frontiers in Immunology 13:866703.","journal-title":"Frontiers in Immunology"},{"key":"2332_CR27","doi-asserted-by":"publisher","first-page":"1197630","DOI":"10.3389\/fimmu.2023.1197630","volume":"14","author":"ML Carbone","year":"2023","unstructured":"Carbone, M. L., A. Capone, M. Guercio, S. Reddel, D. A. Silvestris, and D. Lulli et al. 2023. Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy. Frontiers in Immunology 14:1197630.","journal-title":"Frontiers in Immunology"},{"key":"2332_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000253915","volume":"139","author":"K Balabanov","year":"1969","unstructured":"Balabanov, K., and V. C. Andreev. 1969. I. Tchernozemski. Malignant melanoma and vitiligo. Dermatologica 139:211\u2013219.","journal-title":"Dermatologica"},{"key":"2332_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/pcmr.12947","volume":"34","author":"P Manga","year":"2021","unstructured":"Manga, P., and N. Choudhury. 2021. The unfolded protein and integrated stress response in melanoma and vitiligo. Pigment Cell Melanoma Res 34:204\u2013211.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2332_CR30","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2016.4059","volume":"315","author":"A Ribas","year":"2016","unstructured":"Ribas, A., O. Hamid, A. Daud, F. S. Hodi, J. D. Wolchok, and R. Kefford et al. 2016. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. Journal of the American Medical Association 315:1600\u20131609.","journal-title":"Journal of the American Medical Association"},{"key":"2332_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky, J. M., A. Garcia-Diaz, D. S. Shin, H. Escuin-Ordinas, W. Hugo, and S. Hu-Lieskovan et al. 2016. Mutations associated with acquired resistance to PD-1 Blockade in melanoma. New England Journal of Medicine 375:819\u2013829.","journal-title":"New England Journal of Medicine"},{"key":"2332_CR32","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1038\/ncomms15440","volume":"8","author":"A Sucker","year":"2017","unstructured":"Sucker, A., F. Zhao, N. Pieper, C. Heeke, R. Maltaner, and N. Stadtler et al. 2017. Acquired IFN\u03b3 resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions. Nature Communications 8:15440.","journal-title":"Nature Communications"},{"key":"2332_CR33","doi-asserted-by":"publisher","first-page":"E11101","DOI":"10.1073\/pnas.1807256115","volume":"115","author":"E Persi","year":"2018","unstructured":"Persi, E., Y. I. Wolf, M. D. M. Leiserson, and E. V. Koonin. 2018. Ruppin. Criticality in tumor evolution and clinical outcome. Proc Natl Acad Sci U S A 115:E11101\u2013E10.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2332_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1046\/j.1523-1747.1999.00805.x","volume":"113","author":"JC Becker","year":"1999","unstructured":"Becker, J. C., P. Guldberg, J. Zeuthen, E. B. Br\u00f6cker, and P. T. Straten. 1999. Accumulation of identical T cells in melanoma and vitiligo-like leukoderma. The Journal of Investigative Dermatology 113:1033\u20131038.","journal-title":"The Journal of Investigative Dermatology"},{"key":"2332_CR35","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/eji.200535110","volume":"35","author":"B Palermo","year":"2005","unstructured":"Palermo, B., S. Garbelli, S. Mantovani, E. Scoccia, G. A. Da Prada, and P. Bernabei et al. 2005. Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo. European Journal of Immunology 35:3153\u20133162.","journal-title":"European Journal of Immunology"},{"key":"2332_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","volume":"14","author":"DL Farber","year":"2014","unstructured":"Farber, D. L., and N. A. Yudanin. 2014. Restifo. Human memory T cells: Generation, compartmentalization and homeostasis. Nature Reviews Immunology 14:24\u201335.","journal-title":"Nature Reviews Immunology"},{"key":"2332_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0952-7915(02)00360-6","volume":"14","author":"L Lefran\u00e7ois","year":"2002","unstructured":"Lefran\u00e7ois, L., and D. Masopust. 2002. T cell immunity in lymphoid and non-lymphoid tissues. Current Opinion in Immunology 14:503\u2013508.","journal-title":"Current Opinion in Immunology"},{"key":"2332_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","volume":"138","author":"K Boniface","year":"2018","unstructured":"Boniface, K., C. Jacquemin, A.-S. Darrigade, B. Dessarthe, C. Martins, and N. Boukhedouni et al. 2018. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3. The Journal of Investigative Dermatology 138:355\u2013364.","journal-title":"The Journal of Investigative Dermatology"},{"key":"2332_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s43018-021-00180-1","volume":"2","author":"J Han","year":"2021","unstructured":"Han, J., Y. Zhao, K. Shirai, A. Molodtsov, F. W. Kolling, and J. L. Fisher et al. 2021. Resident and Circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy. Nat Cancer 2:300\u2013311.","journal-title":"Nat Cancer"},{"key":"2332_CR40","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jid.2018.10.032","volume":"139","author":"JM Richmond","year":"2019","unstructured":"Richmond, J. M., J. P. Strassner, M. Rashighi, P. Agarwal, M. Garg, and K. I. Essien et al. 2019. Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo. The Journal of Investigative Dermatology 139:769\u2013778.","journal-title":"The Journal of Investigative Dermatology"},{"key":"2332_CR41","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.it.2023.09.003","volume":"44","author":"V Niederlova","year":"2023","unstructured":"Niederlova, V., O. Tsyklauri, M. Kovar, and O. Stepanek. 2023. IL-2-driven CD8\u2009+\u2009T cell phenotypes: Implications for immunotherapy. Trends in Immunology 44:890\u2013901.","journal-title":"Trends in Immunology"},{"key":"2332_CR42","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy, M. J., and D. J. Cua. 2019. Gaffen. The IL-17 family of cytokines in health and disease. Immunity 50:892\u2013906.","journal-title":"Immunity"},{"key":"2332_CR43","doi-asserted-by":"publisher","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","volume":"7","author":"Y Lili","year":"2012","unstructured":"Lili, Y., W. Yi, Y. Ji, S. Yue, S. Weimin, and L. Ming. 2012. Global activation of CD8\u2009+\u2009cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS One 7:e37513.","journal-title":"PLoS One"},{"key":"2332_CR44","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3389\/fimmu.2019.01198","volume":"10","author":"W-H Boehncke","year":"2019","unstructured":"Boehncke, W.-H. 2019. Brembilla. Autoreactive T-Lymphocytes in inflammatory skin diseases. Frontiers in Immunology 10:1198.","journal-title":"Frontiers in Immunology"},{"key":"2332_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2019.07.016","volume":"59","author":"MR Ruocco","year":"2019","unstructured":"Ruocco, M. R., A. Avagliano, G. Granato, E. Vigliar, S. Masone, and S. Montagnani et al. 2019. Metabolic flexibility in melanoma: A potential therapeutic target. Semin Cancer Biol 59:187\u2013207.","journal-title":"Semin Cancer Biol"},{"key":"2332_CR46","doi-asserted-by":"publisher","first-page":"156516","DOI":"10.1016\/j.cyto.2024.156516","volume":"176","author":"N Sain","year":"2024","unstructured":"Sain, N., V. Hooda, A. Singh, S. Gupta, S. Arava, and A. Sharma. 2024. Macrophage inhibitory factor alters the functionality of macrophages and their involvement in disease pathogenesis of active generalized vitiligo patients. Cytokine 176:156516.","journal-title":"Cytokine"},{"key":"2332_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","volume":"39","author":"GT Motz","year":"2013","unstructured":"Motz, G. T., and G. Coukos. 2013. Deciphering and reversing tumor immune suppression. Immunity 39:61\u201373.","journal-title":"Immunity"},{"key":"2332_CR48","doi-asserted-by":"crossref","unstructured":"Chang, W. L., and C. H. Ko. 2023. The role of oxidative stress in vitiligo: An update on its pathogenesis and therapeutic implications. Cells 12:936.","DOI":"10.3390\/cells12060936"},{"key":"2332_CR49","doi-asserted-by":"crossref","unstructured":"Bellei, B., E. Migliano, and M. Picardo. 2020. A framework of major Tumor-Promoting signal transduction pathways implicated in Melanoma-Fibroblast dialogue. Cancers (Basel) 12:3400.","DOI":"10.3390\/cancers12113400"},{"key":"2332_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2012.04.025","volume":"324","author":"G Comito","year":"2012","unstructured":"Comito, G., E. Giannoni, P. Di Gennaro, C. P. Segura, and G. Gerlini. 2012. Chiarugi. Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer Letters 324:31\u201341.","journal-title":"Cancer Letters"},{"key":"2332_CR51","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","volume":"137","author":"JM Richmond","year":"2017","unstructured":"Richmond, J. M., D. S. Bangari, K. I. Essien, S. D. Currimbhoy, J. R. Groom, and A. G. Pandya et al. 2017. Keratinocyte-Derived chemokines orchestrate T-Cell positioning in the epidermis during vitiligo and May serve as biomarkers of disease. The Journal of Investigative Dermatology 137:350\u2013358.","journal-title":"The Journal of Investigative Dermatology"},{"key":"2332_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/CMR.0000000000000573","volume":"29","author":"IG Motofei","year":"2019","unstructured":"Motofei, I. G. 2019. Melanoma and autoimmunity: Spontaneous regressions as a possible model for new therapeutic approaches. Melanoma Research 29:231\u2013236.","journal-title":"Melanoma Research"},{"key":"2332_CR53","doi-asserted-by":"crossref","unstructured":"Nedelcu, R., A. Dobre, A. Brinzea, I. Hulea, R. Andrei, and S. Zurac et al. 2021. Current challenges in Deciphering Sutton Nevi-Literature review and personal experience. J Pers Med 11:904.","DOI":"10.3390\/jpm11090904"},{"key":"2332_CR54","doi-asserted-by":"publisher","first-page":"1164124","DOI":"10.3389\/fimmu.2023.1164124","volume":"14","author":"L Luo","year":"2023","unstructured":"Luo, L., J. Zhu, Y. Guo, and C. Li. 2023. Mitophagy and immune infiltration in vitiligo: Evidence from bioinformatics analysis. Frontiers in Immunology 14:1164124.","journal-title":"Frontiers in Immunology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02332-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02332-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02332-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:02:48Z","timestamp":1766412168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02332-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2332"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02332-2","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment of the study was approved by the Medical Ethics Committee of the first affiliated hospital of Nanjing Medical University (Ethics approval number: 2022-SR-583). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}